What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement

Albany Med v. HRSA: What the Decision Really Means for 340B Child Site Eligibility

Albany Med v. HRSA: What the Decision Really Means for 340B Child Site Eligibility

In early March 2026, a federal district court issued a significant ruling in Albany Med Health System v. HRSA, challenging long-standing assumptions about when hospital child sites become eligible to participate in the 340B program.

The decision has prompted substantial discussion across the 340B industry, particularly around whether HRSA can require OPAIS registration before participation. But while the ruling may appear straightforward, its practical implications are far more nuanced. Read More >

Virtue 340B

Virtue 340B News & Announcements

Virtue 340B provides independent 340B risk oversight for hospitals and health systems operating in an increasingly complex and scrutinized program environment. Rather than managing programs or selling technology, Virtue delivers objective, independent analysis that helps leadership understand where hidden exposure may exist, what that exposure could mean operationally or financially, and whether current oversight would stand up under external scrutiny. Our work translates complex 340B operational realities into clear, defensible insights that executives can act on with confidence.
Through independent audits, mock HRSA audit simulations, and continuous compliance monitoring, Virtue helps organizations detect operational drift early, strengthen oversight structures, and maintain durable, audit-ready programs. By focusing on prevention, visibility, and governance, not just technical compliance, Virtue 340B equips leadership teams with the clarity they need to protect their organizations and confidently defend how their 340B programs are being managed.

RXinsider Staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

SUBSCRIBE

Name
Subscription Choices
Checkboxes
Subscribe
Receive the latest news, product launches, and insights from RXinsider.

Request information from Albany Med v. HRSA: What the Decision Really Means for 340B Child Site Eligibility

Name
Address
Subscribe